Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank E Jones

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Neuroscience Research|March 1, 2011
The ERBB4 intracellular domain (4ICD) regulates NRG1-induced gene expression in hippocampal neuronsJune G Allison, Partha M Das, Jingjing Ma, et al.
Cancer Research|August 5, 2008
The HER4/4ICD estrogen receptor coactivator and BH3-only protein is an effector of tamoxifen-induced apoptosisAnjali Naresh, Ann D Thor, Susan M Edgerton, et al.
Molecular Cancer Therapeutics|August 12, 2005
Selenium disrupts estrogen receptor (alpha) signaling and potentiates tamoxifen antagonism in endometrial cancer cells and tamoxifen-resistant breast cancer cellsYatrik M Shah, Mariam Al-Dhaheri, Yan Dong, et al.
Breast Cancer Research : BCR|December 21, 2010
Inhibition of breast cancer cell invasion by melatonin is mediated through regulation of the p38 mitogen-activated protein kinase signaling pathwayLulu Mao, Lin Yuan, Lauren M Slakey, et al.
Journal of Nanoscience and Nanotechnology|August 12, 2003
Synthesis and characterization of PtSn/carbon and Pt3Sn/carbon nanocomposites as methanol electrooxidation catalystsFrank E Jones, Stephen B Milne, Bogdan Gurau, et al.
The Journal of Biological Chemistry|June 27, 2014
Hypoxia-inducible factor-1α induces ErbB4 signaling in the differentiating mammary glandIlkka Paatero, Tiffany N Seagroves, Katri Vaparanta, et al.
Carcinogenesis|September 30, 2010
Oncogenic HER2{Delta}16 suppresses miR-15a/16 and deregulates BCL-2 to promote endocrine resistance of breast tumorsDiana M Cittelly, Partha M Das, Virgilio A Salvo, et al.
Development (Cambridge, England)|September 5, 2003
Impaired differentiation and lactational failure of Erbb4-deficient mammary glands identify ERBB4 as an obligate mediator of STAT5Weiwen Long, Kay-Uwe Wagner, K C Kent Lloyd, et al.
Molecular Cancer|June 17, 2010
The ERalpha coactivator, HER4/4ICD, regulates progesterone receptor expression in normal and malignant breast epitheliumJerzy Rokicki, Partha M Das, Jennifer M Giltnane, et al.
Developmental Cell|January 14, 2014
Basal cell signaling by p63 controls luminal progenitor function and lactation via NRG1Nicole Forster, Srinivas Vinod Saladi, Maaike van Bragt, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Neuroscience Research|March 1, 2011
The ERBB4 intracellular domain (4ICD) regulates NRG1-induced gene expression in hippocampal neuronsJune G Allison, Partha M Das, Jingjing Ma, et al.
Cancer Research|August 5, 2008
The HER4/4ICD estrogen receptor coactivator and BH3-only protein is an effector of tamoxifen-induced apoptosisAnjali Naresh, Ann D Thor, Susan M Edgerton, et al.
Molecular Cancer Therapeutics|August 12, 2005
Selenium disrupts estrogen receptor (alpha) signaling and potentiates tamoxifen antagonism in endometrial cancer cells and tamoxifen-resistant breast cancer cellsYatrik M Shah, Mariam Al-Dhaheri, Yan Dong, et al.
Breast Cancer Research : BCR|December 21, 2010
Inhibition of breast cancer cell invasion by melatonin is mediated through regulation of the p38 mitogen-activated protein kinase signaling pathwayLulu Mao, Lin Yuan, Lauren M Slakey, et al.
Journal of Nanoscience and Nanotechnology|August 12, 2003
Synthesis and characterization of PtSn/carbon and Pt3Sn/carbon nanocomposites as methanol electrooxidation catalystsFrank E Jones, Stephen B Milne, Bogdan Gurau, et al.
The Journal of Biological Chemistry|June 27, 2014
Hypoxia-inducible factor-1α induces ErbB4 signaling in the differentiating mammary glandIlkka Paatero, Tiffany N Seagroves, Katri Vaparanta, et al.
Carcinogenesis|September 30, 2010
Oncogenic HER2{Delta}16 suppresses miR-15a/16 and deregulates BCL-2 to promote endocrine resistance of breast tumorsDiana M Cittelly, Partha M Das, Virgilio A Salvo, et al.
Development (Cambridge, England)|September 5, 2003
Impaired differentiation and lactational failure of Erbb4-deficient mammary glands identify ERBB4 as an obligate mediator of STAT5Weiwen Long, Kay-Uwe Wagner, K C Kent Lloyd, et al.
Molecular Cancer|June 17, 2010
The ERalpha coactivator, HER4/4ICD, regulates progesterone receptor expression in normal and malignant breast epitheliumJerzy Rokicki, Partha M Das, Jennifer M Giltnane, et al.
Developmental Cell|January 14, 2014
Basal cell signaling by p63 controls luminal progenitor function and lactation via NRG1Nicole Forster, Srinivas Vinod Saladi, Maaike van Bragt, et al.
Pageof 5